Autonomix Medical, Inc. Common Stock
AMIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $2 | $2 | $1 |
| G&A Expenses | $0 | $2 | $0 | $2 |
| SG&A Expenses | $5 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $3 | $3 | $3 |
| Operating Income | -$8 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$7 | -$3 | -$3 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS | -1.38 | -1.07 | -1.81 | -1.46 |
| % Growth | -29% | 40.9% | -24% | – |
| EPS Diluted | -1.38 | -1.07 | -1.81 | -1.46 |
| Weighted Avg Shares Out | 5 | 3 | 2 | 2 |
| Weighted Avg Shares Out Dil | 5 | 3 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |